Relay Therapeutics, Inc
Price
FilingsNewest: 424B5, Offering prospectusAug 6 →InsidersNo open-market buys. 7 insiders sold $129.0M, 19 of 38 sales on a 10b5-1 plan.→HoldersSB Investment Advisers (uk) 12.8%FMR 9.2%Casdin Capital 7.3%→PeersClosest companies: TNGX, TYRA, BDTX→
From the filings
Figures
- Revenue
- $10.3Mlast 12 months
- Net income
- −$286.0Mlast 12 months
- Operating cash flow
- −$213.4Mlast 12 months
- Cash and equivalents
- $121.2Mat the last balance sheet
- Shares outstanding
- 218.5M shareson issue